Literature DB >> 32306165

Challenges in conducting clinical research studies in pregnant women.

Monique McKiever1, Heather Frey1, Maged M Costantine2.   

Abstract

Maternal mortality and morbidity continue to rise in the United States. Despite these trends there are limited novel interventions to investigate and improve these metrics, partly due to research protocol limitations which restrict participation of pregnant women. Inclusion of pregnant women in research studies is integral to the process of obtaining important information regarding the safety and efficacy of therapeutics or interventions to improve maternal health and pregnancy outcomes. While significant changes in research practices have resulted in an increase of female participants, there remains a paucity of research trials directly targeting pregnant and lactating women. This article provides an overview of issues surrounding inclusion of pregnant or breastfeeding women in research studies, and includes historical perspectives, navigating concerns over safety profile, considerations for appropriate development, and future perspectives.

Entities:  

Keywords:  Breastfeeding; Clinical research; Drug development; Obstetrics; Pharmacology; Pregnancy

Year:  2020        PMID: 32306165      PMCID: PMC8237366          DOI: 10.1007/s10928-020-09687-z

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  43 in total

1.  Thalidomide back--under strict control.

Authors:  C Marwick
Journal:  JAMA       Date:  1997-10-08       Impact factor: 56.272

Review 2.  Challenges of studying drugs in pregnancy for off-label indications: pravastatin for preeclampsia prevention.

Authors:  Kirsten Lawrence Cleary; Kelly Roney; Maged Costantine
Journal:  Semin Perinatol       Date:  2014-10-12       Impact factor: 3.300

3.  ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-11       Impact factor: 7.661

4.  The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model.

Authors:  Mollie McDonnold; Esther Tamayo; Talar Kechichian; Phyllis Gamble; Monica Longo; Gary D V Hankins; George R Saade; Maged M Costantine
Journal:  Am J Obstet Gynecol       Date:  2014-01-08       Impact factor: 8.661

5.  Designing drug trials: considerations for pregnant women.

Authors:  Jeanne S Sheffield; David Siegel; Mark Mirochnick; R Phillips Heine; Christine Nguyen; Kimberly L Bergman; Rada M Savic; Jill Long; Kelly E Dooley; Mirjana Nesin
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

6.  The effect of maternal pravastatin therapy on adverse sensorimotor outcomes of the offspring in a murine model of preeclampsia.

Authors:  Alissa R Carver; Esther Tamayo; J Regino Perez-Polo; George R Saade; Gary D V Hankins; Maged M Costantine
Journal:  Int J Dev Neurosci       Date:  2013-11-25       Impact factor: 2.457

7.  Lessons learned in pediatric clinical research to evaluate safe and effective use of drugs in pregnancy.

Authors:  Daniel Gonzalez; Kim A Boggess; Michael Cohen-Wolkowiez
Journal:  Obstet Gynecol       Date:  2015-04       Impact factor: 7.623

Review 8.  Thalidomide-induced teratogenesis: history and mechanisms.

Authors:  Neil Vargesson
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-04

9.  Medication use in pregnancy: a cross-sectional, multinational web-based study.

Authors:  A Lupattelli; O Spigset; M J Twigg; K Zagorodnikova; A C Mårdby; M E Moretti; M Drozd; A Panchaud; K Hämeen-Anttila; A Rieutord; R Gjergja Juraski; M Odalovic; D Kennedy; G Rudolf; H Juch; A Passier; I Björnsdóttir; H Nordeng
Journal:  BMJ Open       Date:  2014-02-17       Impact factor: 2.692

10.  Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model.

Authors:  Alissa R Carver; Maria Andrikopoulou; Jun Lei; Esther Tamayo; Phyllis Gamble; Zhipeng Hou; Jiangyang Zhang; Susumu Mori; George R Saade; Maged M Costantine; Irina Burd
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

View more
  3 in total

1.  Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries.

Authors:  Devin D Smith; Jessica L Pippen; Adebayo A Adesomo; Kara M Rood; Mark B Landon; Maged M Costantine
Journal:  Am J Perinatol       Date:  2020-05-19       Impact factor: 1.862

Review 2.  Maternal-Fetal Drug Development: An Industry Perspective.

Authors:  Janelle Burnham; Edress Darsey
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

3.  A pharmacometrician's role in enhancing medication use in pregnancy and lactation.

Authors:  Sara K Quinney; Peter L Bonate
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-08       Impact factor: 2.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.